Hereditary tumor syndromes. Cutaneous manifestations and molecular pathogenesis of Gorlin and Cowden syndromes;Hereditäre tumorsyndrome. Kutane manifestationen und molekulare pathogenese am beispiel des Gorlin- und Cowden-syndroms

Hautarzt

Volumn 55, Issue 10, 2004, Pages 942-951

  Reifenberger, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cowden syndrome; Naevoid basal cell carcinoma syndrome; PTCH; PTEN; Tumor suppressor gene

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLOPAMIN; ENZYME INHIBITOR; IMIQUIMOD; N (3 METHOXYBENZYL) 3,3 DIMETHYL N [1 (3,4 METHYLENEDIOXYBENZYL) 2 (1 PIPERAZINYLCARBONYL) 4 PYRROLIDINYL]BUTYRAMIDE; PROTEIN INHIBITOR; RAPAMYCIN; RETINOID; TEMSIROLIMUS; UNCLASSIFIED DRUG;

ACRAL KERATOSIS; ANTINEOPLASTIC ACTIVITY; AUTOSOMAL DOMINANT DISORDER; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BENIGN TUMOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; COWDEN SYNDROME; DEVELOPMENTAL DISORDER; DRUG EFFICACY; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FACE TRICHILEMMOMAS; FAMILIAL CANCER; GENE IDENTIFICATION; GENE MUTATION; GERM LINE; HUMAN; KERATOSIS; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; MUCOCUTANEOUS PAPILLOMATOSIS; NONHUMAN; PAPILLOMATOSIS; PATHOGENESIS; PHOTODYNAMIC THERAPY; PTCH GENE; PTEN GENE; REVIEW; SKIN DEFECT; SKIN MANIFESTATION; THYROID CANCER; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; BASAL CELL NEVUS SYNDROME; DISEASE MODELS, ANIMAL; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; MICE; SKIN; SKIN NEOPLASMS;

EID: 6344291071     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0800-x     Document Type: Review

References (33)

1. Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181-193
2. Aszterbaum M, Epstein J, Oro A et al. (1999) Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5:1285-1291
3. Backman SA, Ghazarian D, So K et al. (2004) Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA 10:1725-1730
4. Backman SA, Stambolic V, Suzuki A et al. (2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29:396-403
5. Berman DM, Karhadkar SS, Hallahan AR et al. (2002) Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559-1561
6. Biesecker LG, Happle R, Mulliken JB et al. (1999) Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 84:389-395
7. Brellier F, Marionnet C, Chevallier-Lagente O et al. (2004) Ultraviolet irradiation represses PATCHED gene transcription in human epidermal keratinocytes through an activator protein-1-dependent process. Cancer Res 64:2699-2704
8. Cohen MM Jr (2003) The hedgehog signaling network. Am J Med Genet 123:5-28
9. DiGiovanna JJ (2001) Retinoid chemoprevention in patients at high risk for skin cancer. Med Pediatr Oncol 36:564-567
10. Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22:183-198
11. Fisher GJ,Talwar HS, Lin J et al. (1998) Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 101:1432-1440
12. Gorlin RJ (1995) Nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113-125
13. Gorlin RJ, Goltz RW (1960) Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 262:908-192
14. Hickson ID (2003) RecQ helicases: caretakers of the genome. Nat Rev Cancer 3:169-178
15. Kagy MK, Amonette R (2000) The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg. 26:577-578
16. Kimonis VE, Goldstein AM, Pastakia B et al. (1997) Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69:299-308
17. Kopera D, Cerroni L, Fink-Puches R, Kerl H (1996) Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol 34:937-939
18. Lloyd KM 2nd, Dennis M (1963) Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 58:136-142
19. Lum L, Beachy PA (2004) The Hedgehog response network: sensors, switches, and routers. Science 304:1755-1759
20. Luo J, Manning BD, Cantley LC (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4:257-262
21. Mita MM, Mita A, Rowinsky EK (2003) Mammalian target of rapamycin: a new molecular target for breast cancer. Clin Breast Cancer 4:126-137
22. Pilarski R, Eng C (2004) Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323-326
23. Reifenberger J, Rauch L, Beckmann MW et al. (2003) Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation. Br J Dermatol 148:1040-1046
24. Reifenberger J, Schön MP (2003) Epitheliale Tumoren der Haut. Molekulare Grundlagen und pathogeneseorientierte Therapie. Hautarzt 54:1164-1170
25. Roy S, Ingham PW (2002) Hedgehogs tryst with the cell cycle. J Cell Sci 115:4393-4397
26. Schön M, Bong AB, Drewniok C et al. (2003) Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 95:1138-1149
27. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155-168
28. Stockfleth E, Ulrich C, Hauschild A et al. (2002) Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 12:569-572
29. Tabs S, Avci O (2004) Induction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivity. Eur J Dermatol 14:96-102
30. Waite KA, Eng C (2002) Protean PTEN: form and function. Am J Hum Genet 70:829-844
31. Wicking C, Shanley S, Smyth I et al. (1997) Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60:21-26
32. Williams JA, Guicherit OM, Zaharian BI et al. (2003) Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA 100:4616-4621
33. Zhou XP, Waite KA, Pilarski R et al. (2003) Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73:404-411